Al-Dabbagh Najwa Mohammed, Al-Dohayan Nourah, Arfin Misbahul, Tariq Mohammad
Department of Ophthalmology, Armed Forces Hospital, Riyadh, Saudi Arabia.
Mol Vis. 2009;15:912-9. Epub 2009 May 4.
The frequencies of apolipoprotein E (APOE) alleles and genotypes were examined in 230 Saudi subjects including primary open-angle glaucoma (POAG; n=60) and primary angle-closure glaucoma (PACG; n=40) patients as well as 130 control subjects.
The presence of glaucoma in patients was based on clinical examination and/or ophthalmic records. The APOE allele frequency (epsilon2, epsilon3, and epsilon4) was studied by polymerase chain reaction (PCR) followed by reverse-hybridization and restriction fragment length polymorphism techniques.
Analysis of data showed a complete absence of epsilon2 allele and a significantly lower frequency of the epsilon3 allele in primary glaucoma patients (90.5%) compared to the control subjects (95.7%, p=0.034, relative risk [RR]=0.473, protective fraction [PF]=0.318). The frequency of the epsilon4 allele was significantly higher in the glaucoma patients (9.5%) compared to the control subjects (4.2%, p=0.034, RR=2.169, etiological fraction [EF]=0.329). The epsilon3/epsilon3 genotype was more common in controls than patients (p=0.060, RR=0.465, PF=0.322). The difference in genotype (epsilon3/epsilon4) was not statistically significant between the two groups (p=0.283). Genotype epsilon4/epsilon4 was found only in 3% of patients while being completely absent in the controls (p=0.080). The genotypes, epsilon2/epsilon2, epsilon2/epsilon3, and epsilon2/epsilon4, were absent in both the test and control groups. When patients were divided on the basis of types of glaucoma, POAG patients had a significantly higher frequency of epsilon4 allele and epsilon4/epsilon4 genotype than controls whereas there was no significant difference between PACG patient and control groups in frequencies of APOE alleles and genotypes.
This study indicates that the epsilon4 allele may be associated with POAG and could be a risk factor while epsilon3 may be protective for POAG, and APOE polymorphisms may not be associated at all with PACG in Saudis.
在230名沙特受试者中检测载脂蛋白E(APOE)等位基因和基因型的频率,这些受试者包括原发性开角型青光眼(POAG;n = 60)和原发性闭角型青光眼(PACG;n = 40)患者以及130名对照受试者。
患者青光眼的诊断基于临床检查和/或眼科记录。通过聚合酶链反应(PCR),随后进行反向杂交和限制性片段长度多态性技术研究APOE等位基因频率(ε2、ε3和ε4)。
数据分析显示,原发性青光眼患者中完全不存在ε2等位基因,且ε3等位基因频率(90.5%)显著低于对照受试者(95.7%,p = 0.034,相对风险[RR]=0.473,保护率[PF]=0.318)。青光眼患者中ε4等位基因频率(9.5%)显著高于对照受试者(4.2%,p = 0.034,RR = 2.169,病因分数[EF]=0.329)。ε3/ε3基因型在对照组中比患者中更常见(p = 0.060,RR = 0.465,PF = 0.322)。两组之间基因型(ε3/ε4)的差异无统计学意义(p = 0.283)。ε4/ε4基因型仅在3%的患者中发现,而在对照组中完全不存在(p = 0.080)。ε2/ε2、ε2/ε3和ε2/ε4基因型在试验组和对照组中均不存在。当根据青光眼类型对患者进行分组时,POAG患者中ε4等位基因和ε4/ε4基因型的频率显著高于对照组,而PACG患者和对照组之间APOE等位基因和基因型的频率无显著差异。
本研究表明,ε4等位基因可能与POAG相关,可能是一个危险因素,而ε3可能对POAG有保护作用,并且在沙特人中,APOE多态性可能与PACG完全无关。